The Rhythm of the Night
Gene therapy could provide long-term relief from elevated nocturnal IOP
Intraocular pressure (IOP) is affected by both posture and circadian rhythm – with peak IOPs achieved at night when people are both supine and sleeping. Accordingly, nocturnal IOP control is an important part of glaucoma management, yet some topical glaucoma medications like brimonidine tartrate and timolol maleate fail to significantly reduce nighttime IOP. A drug that can control IOP when patients are sleeping (and therefore not administering eyedrops) would certainly be worth having.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.